Małgorzata Nowicka
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Intensive Care Unit Cognitive Disorders 3
-
- Anesthesia and Sedative Agents 3
- Co-authors
- Charlotte SonesonMark D. RobinsonLukas M. WeberWalter BordognaAlice T. ShawTony MokSolange PetersShirish M. Gadgeel
- Journals
- Journal of Clinical Oncology (5 papers)Clinical Cancer Research (2 papers)Frontiers in Psychiatry (2 papers)Annals of Oncology (2 papers)Cancer (1 paper)
- Partner nations
- SwitzerlandPolandUnited States
In The Last Decade
Małgorzata Nowicka
24 papers receiving 663 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 337
- Pulmonary and Respiratory Medicine 343
- Cancer Research 151
- Biophysics 29
- Molecular Biology 265
Countries citing papers authored by Małgorzata Nowicka
This map shows the geographic impact of Małgorzata Nowicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Nowicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Nowicka more than expected).
Fields of papers citing papers by Małgorzata Nowicka
This network shows the impact of papers produced by Małgorzata Nowicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Nowicka. The network helps show where Małgorzata Nowicka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Małgorzata Nowicka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 23 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 31 | |
| 9 | 2020 | 6 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 21 | |
| 12 | 2019 | 115 | |
| 13 | Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study Hit paper breakdown → | 2019 | 319 |
| 14 | 2019 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2016 | 79 | |
| 18 | 2013 | 3 | |
| 19 | Prevalence of hypothalamic-pituitary tumours - retrospective analysis of 20-year own material. | 2012 | 1 |
| 20 | 2007 | 24 |
About Małgorzata Nowicka
Małgorzata Nowicka is a scholar working on Critical Care and Intensive Care Medicine, Anesthesiology and Pain Medicine, Applied Psychology, Oncology and Cancer Research, having authored 24 papers that have together received 674 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Intensive Care Unit Cognitive Disorders (3 papers), Anesthesia and Sedative Agents (3 papers), Advanced Breast Cancer Therapies (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (337 citations), Pulmonary and Respiratory Medicine (343 citations), Cancer Research (151 citations), Biophysics (29 citations) and Molecular Biology (265 citations). Małgorzata Nowicka has collaborated with scholars based in Switzerland, Poland and United States. Frequent co-authors include Charlotte Soneson, Mark D. Robinson, Lukas M. Weber, Walter Bordogna, Alice T. Shaw, Tony Mok, Solange Peters, Shirish M. Gadgeel, Li Zhang and Byoung Chul Cho. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Frontiers in Psychiatry, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.